Citigroup Inc. Has $19.65 Million Position in Acadia Healthcare Company, Inc. $ACHC

Citigroup Inc. increased its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 7.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 793,596 shares of the company’s stock after buying an additional 56,109 shares during the quarter. Citigroup Inc. owned 0.86% of Acadia Healthcare worth $19,649,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Principal Financial Group Inc. raised its stake in shares of Acadia Healthcare by 112.1% in the third quarter. Principal Financial Group Inc. now owns 442,943 shares of the company’s stock valued at $10,967,000 after purchasing an additional 234,107 shares in the last quarter. First Citizens Bank & Trust Co. lifted its holdings in shares of Acadia Healthcare by 164.1% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 59,123 shares of the company’s stock worth $1,464,000 after acquiring an additional 36,733 shares during the period. Oppenheimer Asset Management Inc. boosted its position in shares of Acadia Healthcare by 85.1% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 28,683 shares of the company’s stock valued at $651,000 after acquiring an additional 13,188 shares in the last quarter. Public Sector Pension Investment Board bought a new stake in Acadia Healthcare in the third quarter valued at about $8,919,000. Finally, Caxton Associates LLP raised its position in Acadia Healthcare by 1,234.5% in the second quarter. Caxton Associates LLP now owns 173,482 shares of the company’s stock worth $3,936,000 after purchasing an additional 160,482 shares in the last quarter.

Acadia Healthcare Stock Performance

ACHC stock opened at $22.29 on Friday. The company has a 50 day moving average price of $14.64 and a 200 day moving average price of $18.54. Acadia Healthcare Company, Inc. has a fifty-two week low of $11.43 and a fifty-two week high of $42.85. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.55 and a quick ratio of 1.44. The stock has a market capitalization of $2.06 billion, a PE ratio of -1.83, a price-to-earnings-growth ratio of 7.04 and a beta of 0.89.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, February 25th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of $0.03 by $0.04. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.The company had revenue of $821.46 million during the quarter, compared to analysts’ expectations of $800.10 million. During the same period last year, the firm earned $0.64 EPS. The business’s revenue for the quarter was up 6.1% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. Analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Analyst Ratings Changes

Several research firms have recently weighed in on ACHC. Jefferies Financial Group lowered Acadia Healthcare to a “hold” rating in a research note on Thursday, January 22nd. Cantor Fitzgerald set a $17.00 price objective on Acadia Healthcare in a research note on Wednesday, December 3rd. Guggenheim reduced their target price on shares of Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating on the stock in a research note on Monday. UBS Group increased their target price on shares of Acadia Healthcare from $24.00 to $27.00 and gave the stock a “buy” rating in a research report on Thursday. Finally, Leerink Partners boosted their price target on shares of Acadia Healthcare from $14.00 to $22.00 and gave the company a “market perform” rating in a research report on Thursday. Seven analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $20.69.

Key Stories Impacting Acadia Healthcare

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Q4 revenue topped estimates — revenue of ~$821.5M (≈6% YoY growth) and rising admissions/patient days, which investors interpreted as signs of operational recovery. Acadia Healthcare’s (NASDAQ:ACHC) Q4 CY2025 Sales Top Estimates, Stock Jumps 10.8%
• Positive Sentiment: Company issued upbeat Q1 2026 guidance (EPS $0.25–$0.30 vs. consensus $0.11 and revenue $820–$830M vs. consensus ~$799.5M), suggesting sequential improvement into the year — a near‑term catalyst for the rally. Acadia Healthcare Announces Fourth Quarter and 2025 Results
• Positive Sentiment: Multiple analysts raised targets and reiterated buys/outperform (RBC to $28, UBS to $27, TD Cowen to $24), providing fresh broker support and likely amplifying the rally. Benzinga — analyst target/ratings summaries
• Neutral Sentiment: Opinion pieces and analyst notes highlight a returning CEO and new management strategy that could improve execution; these are longer‑term positives but don’t guarantee immediate financial turnaround. Acadia Healthcare: New Management Deserves A Shot At Turning Business Around
• Negative Sentiment: FY‑2026 EPS guidance was lowered relative to sell‑side consensus (guidance $1.30–$1.55 vs. consensus ~$1.75), which caps upside and raises questions about full‑year margins and profitability. Acadia Healthcare Announces Fourth Quarter and 2025 Results
• Negative Sentiment: EPS collapsed year‑over‑year (reported $0.07 vs $0.64 prior year) and operating profit fell sharply — a reminder that revenue strength hasn’t yet translated into sustained earnings recovery. Acadia Healthcare Q4 Earnings Beat Estimates on Rising Admissions
• Negative Sentiment: Large short interest reported earlier in February (≈32.45M shares, ~35.9% sold short; ~7.3 days to cover) increases volatility risk — it can both pressure the stock and set up rapid squeezes. (Data reported in short‑interest updates.)

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.